Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

MALDI-TOF Mass Spectrometry

MALDI-TOF Mass Spectrometry

Mass spectrometry is a powerful characterization technique that can identify and separate a wide variety of compounds ranging from chemical to biological entities, based on their mass-to-charge ratio (m/z). The instruments that allow this detection, known as mass spectrometers, have three components: an ion source, a mass analyzer, and a detector. These spectrometers differ based on the nature of their ion source and analyzers.Matrix-assisted laser desorption ionization (MALDI) is a commonly...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pancreatic Cancer Early Detection Biomarkers for High-Risk Individuals: Insights From the PRECEDE Consortium.

International journal of cancer·2026

Same author

International Union of Basic and Clinical Pharmacology. CXXII. Applying an objective evaluation to the status of class A orphan G protein-coupled receptors.

Pharmacological reviews·2026

Same author

Cigarette smoking drives earlier development of pancreatic adenocarcinoma among carriers of hereditary pancreatic cancer susceptibility genes.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]·2026

Same author

A Biomarker Panel for the Detection of Pancreatic Cancer.

Cancers·2026

Same author

Development of a multiplex assay for early detection of pancreatic cancer in high-risk groups.

BMC cancer·2026

Same author

Reply.

Gastroenterology·2026

Same journal

Thymidylate synthase inhibitory drugs induce p53-dependent pathways differently.

PloS one·2026

Same journal

Top-down and bottom-up attention for joint pattern classification and reconstruction.

PloS one·2026

Same journal

Short- and long-term scaling behavior of blood pressure and pulse arrival time during sleep in healthy controls and patients with obstructive sleep apnea.

PloS one·2026

Same journal

Double DQN-based secrecy energy efficiency and fairness performance in IRS-assisted NOMA systems with friendly jamming.

PloS one·2026

Same journal

10 recommendations for strengthening citizen science for improved societal and ecological outcomes: A co-produced analysis of challenges and opportunities in the 21st century.

PloS one·2026

Same journal

Paying in public: Peer effects, impression management, and willingness to pay on digital payment platforms.

PloS one·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 10, 2026

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

The Marker State Space (MSS) method for classifying clinical samples.

Brian P Fallon¹, Bryan Curnutte, Kevin A Maupin

¹Laboratory of Cancer Immunodiagnostics, Van Andel Institute, Grand Rapids, Michigan, USA.

|June 11, 2013

Summary

This summary is machine-generated.

Marker State Space (MSS) is a new strategy for developing biomarker panels to classify patients by accounting for distinct patient subclasses. This method effectively identifies patient subgroups, improving diagnostic accuracy for diseases like pancreatic cancer.

More Related Videos

Spatial Molecular Imaging of the Glycome Using Mass Spectrometry

Spatial Molecular Imaging of the Glycome Using Mass Spectrometry

Published on: November 28, 2025

Related Experiment Videos

Last Updated: May 10, 2026

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

Spatial Molecular Imaging of the Glycome Using Mass Spectrometry

Spatial Molecular Imaging of the Glycome Using Mass Spectrometry

Published on: November 28, 2025

Area of Science:

Biomedical Science
Computational Biology
Medical Diagnostics

Background:

Accurate clinical biomarkers are difficult to develop due to patient and disease diversity.
Existing methods often struggle to account for completely distinct patient subclasses.
Utilizing multiple markers is a promising approach to capture subclass-specific information.

Purpose of the Study:

To introduce a novel strategy, Marker State Space (MSS), for developing robust biomarker panels.
To demonstrate MSS's ability to model and classify patients within highly divergent subclasses.
To assess the performance of MSS in discriminating between disease cases and controls.

Main Methods:

Marker State Space (MSS) defines "marker states" based on all possible patterns of high and low values across a panel of markers.
Each marker state is designated as either a case or control state.
Samples are classified based on the marker state they occupy within the defined space.

Main Results:

MSS successfully defined multi-marker panels that were robust in cross-validation and training/test set analyses.
The classification accuracy of MSS was comparable to several other established classification algorithms.
A three-marker panel developed using MSS effectively discriminated pancreatic cancer patients from control subjects, revealing distinct patient subclasses.

Conclusions:

Marker State Space (MSS) offers a straightforward and effective approach for modeling highly divergent patient subclasses.
This strategy enhances the development of biomarker panels by explicitly addressing patient heterogeneity.
MSS shows potential adaptability for diverse applications beyond the studied disease context.